Arun V J: Fresh Whole Blood vs Evidence-Based Transfusion
Arun V. J.,Specialist at MVR Cancer Centre and Research Institute, Member of International Society of Blood Transfusion (ISBT) and ADRP: The Association for Blood Donor Professionals, Doctor at Malabar Medical College Hospital and Research Centre, shared a post on LinkedIn:
“Who Are You To Decide The Treatment Of My Patient?
I want a Jurassic-era treatment.
Iykyk
This is a typical conversation with an old-school consultant.
Hb: 10.5; all coagulation profile normal.
Post op patient with oozing, completely hemodynamically stable.
Request was for fresh whole blood.
(No, we don’t unnecessarily transfuse blood. We follow international guidelines.)
(No, nothing is done on a whim)
Anything out of the ordinary, I make it a point to call and enquire if there was something we missed.
I asked if we should work up for any coagulopathy and switch to components if needed (very politely and subserviently, as Indian Healthcare demands).
Response: We rely too much on Jurassic Era idiocy masked as intuition or Gut feeling.
Patients have not died till now IN FRONT of us due to blood transfusion (which is not a justification).
How do you handle such scenarios?
Have you come across such a difficult conversation?”

Stay updated with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis